ECDGA Applauds FDA Approval of Cobimetinib to Treat Erdheim-Chester Disease Dec 30, 2022Cobimetinib is an anti-cancer medication that was first approved for the treatment of melanomas.
A New Year, a New Care Center for Erdheim-Chester Patients in the Netherlands Dec 30, 2021Erasmus University Medical Center in Rotterdam joins a network of hospitals skilled in treating Erdheim-Chester disease patients.
NCCN Guidelines for Histiocytosis Clarify Best Practices for Recently-Defined Cancers Dec 30, 2021New clinical practice guidelines from National Comprehensive Cancer Network focus on workup and management for three main adult histiocytic disorders.
Rare Disease Care Network Now Serves Michigan Patients Dec 30, 2021The Erdheim-Chester Disease Global Alliance is proud to announce the first ECD Referral Care Center to be located in Michigan.
2021 Erdheim-Chester Disease Virtual Medical Symposium Dec 30, 2021Tuesday, November 16, 2021: During this conference, medical professionals from around the world gathered to share scientific findings, patient outcomes, and case studies related to Erdheim-Chester Disease and other histiocytic disorders.
